The trajectory of Viagra, initially marketed by copyright, presents a intricate case study for investors considering the drug landscape . Despite its groundbreaking success and impact of countless in sales, the exclusivity end has opened the way for competing medications, greatly eroding income potential . This shift raises questions about the long